ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,509Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 252

$644K Total Retail Price of All Prescriptions

Rank: 64 out of 252

632 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 632 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 632 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 11,476 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 608 606 1 1
SIMVASTATIN 541 537 2 2
AMLODIPINE BESYLATE 496 496 3 4
LISINOPRIL 404 404 4 3
OMEPRAZOLE 380 378 5 6
METFORMIN HCL 349 349 6 9
POTASSIUM CHLORIDE 338 337 7 8
ATORVASTATIN CALCIUM 276 276 8 16
CITALOPRAM HBR 232 232 9 15
FUROSEMIDE 208 207 10 7
ZOLPIDEM TARTRATE 204 204 11 21
DONEPEZIL HCL 204 204 11 28
PRAVASTATIN SODIUM 182 182 13 12
TRAMADOL HCL 175 174 14 17
HYDROCHLOROTHIAZIDE 174 174 15 13
ATENOLOL 173 173 16 18
GLIMEPIRIDE 167 167 17 40
METOPROLOL SUCCINATE 166 166 18 19
HYDROCODONE-ACETAMINOPHEN 161 161 S3 19 5
WARFARIN SODIUM 146 146 20 14
GABAPENTIN 143 143 21 11
FLUTICASONE PROPIONATE 135 131 22 36
ESCITALOPRAM OXALATE 134 134 23 56
NAMENDA 129 129 24 41
METOPROLOL TARTRATE 117 117 25 10
TAMSULOSIN HCL 116 116 26 26
TRIAMTERENE-HCTZ 97 97 27 33
DIOVAN 96 96 28 38
LOSARTAN POTASSIUM 91 91 29 24
ALENDRONATE SODIUM 89 89 30 32
SYNTHROID 85 85 31 47
RAMIPRIL 84 84 32 71
CARVEDILOL 81 81 33 22
CLOPIDOGREL 76 76 34 29
MIRTAZAPINE 75 75 35 58
TRICOR 71 71 36 145
ADVAIR DISKUS 71 71 36 63
TRAZODONE HCL 67 67 38 31
LANTUS SOLOSTAR 64 64 39 109
MELOXICAM 62 62 40 20
DIGOXIN 62 62 40 44
VENTOLIN HFA 60 60 42 102
SERTRALINE HCL 60 60 42 27
ALLOPURINOL 59 59 44 30
CRESTOR 57 57 45 34
EXELON 56 56 46 154
LEXAPRO 55 55 47 224
GLIPIZIDE ER 55 55 47 90
AMITRIPTYLINE HCL 53 53 R 49 46
JANUVIA 52 52 50 88
ROPINIROLE HCL 51 51 51 84
PLAVIX 51 51 51 43
PANTOPRAZOLE SODIUM 51 51 51 62
SPIRIVA 50 50 54 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.